banner2

Getting started
Dabigatran Etexilate Mesylate

Dabigatran Etexilate Mesylate - Factory, Suppliers, Manufacturers from China

Dabigatran Etexilate Mesylate, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Dabigatran Etexilate Mesylate CAS 872728-81-9 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Dabigatran Etexilate Mesylate CAS 872728-81-9 Purity >99.0% (HPLC) Antithrombotic
Read More

4-Aminobenzamidine Dihydrochloride CAS 2498-50-2 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4-Aminobenzamidine Dihydrochloride CAS 2498-50-2 Purity >98.0% (HPLC)

N-(4-Cyanophenyl)glycine CAS 42288-26-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — N-(4-Cyanophenyl)glycine CAS 42288-26-6 Dabigatran Etexilate Mesylate Intermediate Purity >99.0% (HPLC)

Hexyl Chloroformate CAS 6092-54-2 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Hexyl Chloroformate CAS 6092-54-2 Purity >98.0% (GC) Dabigatran Etexilate Mesylate Intermediate

Dabigatran Etexilate Mesylate CAS 872728-81-9 Purity >99.0% (HPLC) Antithrombotic

Imatinib Mesylate CAS 220127-57-1 Assay 98.0%~102.0% Ph+CML API Factory High Quality

Lenvatinib Mesylate CAS 857890-39-2 Assay 98.0~102.0% Factory

banner4

Top Selling Products

Related Blog
Reviews

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.10.30 08:03:33
2022.07.28 05:38:33
2022.07.22 07:45:54
2022.06.15 20:07:46
2022.02.12 23:06:44
2021.11.08 02:59:37

related search